Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.628
-0.021 (-3.29%)
At close: Mar 9, 2026, 4:00 PM EDT
0.698
+0.070 (11.08%)
After-hours: Mar 9, 2026, 7:43 PM EDT
Company Description
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China.
The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors.
The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025.
Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Cellyan Biotechnology Co., Ltd
| Country | Hong Kong |
| Founded | 2016 |
| IPO Date | Jan 15, 2025 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Chenyu Liang |
Contact Details
Address: Well Town Industrial Building, Room B1, 5th Floor Yau Tong, 999077 Hong Kong | |
| Phone | 852 2618 9289 |
| Website | 9zt.hk |
Stock Details
| Ticker Symbol | HKPD |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002007702 |
| CUSIP Number | G6365B104 |
| ISIN Number | KYG6365B1041 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Chenyu Liang | Chief Executive Officer and Director |
| Shu Liu | Chief Financial Officer |
| Zifeng Wang | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 16, 2026 | 6-K | Report of foreign issuer |
| Dec 31, 2025 | 6-K | Report of foreign issuer |
| Dec 17, 2025 | 6-K | Report of foreign issuer |
| Nov 24, 2025 | 6-K | Report of foreign issuer |
| Nov 12, 2025 | 6-K | Report of foreign issuer |
| Nov 12, 2025 | SCHEDULE 13D | Filing |
| Oct 7, 2025 | 6-K | Report of foreign issuer |
| Sep 11, 2025 | 6-K | Report of foreign issuer |
| Aug 14, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Jul 31, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |